Our cohort of SSc patients displayed a downregulation of the nrf2 pathway (i.e., nrf2 and nrf2-target genes GCL, HO-1, and TRX) in fibroblasts from fibrotic skin. The gene discussed is TXN; the disease is systemic sclerosis.